This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ThermoGenesis Presentation At Rodman & Renshaw Conference

RANCHO CORDOVA, Calif., Sept. 7, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011.

The Company's presentation by Mr. Matthew T. Plavan, the Company's Chief Financial Officer and Executive Vice President, Business Development, will begin at 10:00 am, Eastern Standard Time ( 7:00 am, Pacific Standard Time), and will be held at the Waldorf Astoria, located at 301 Park Avenue, New York, NY 10022.


The presentation will be webcast live and archived for 90 days, streaming video and PowerPoint slides.  Access is available by logging on to the conference website or by going to the Company's website It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About ThermoGenesis Corp.

ThermoGenesis Corp. ( is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products.

ThermoGenesis Corp.Web site: http://www.thermogenesis.comContact: Investor Relations+1-916-858-5107, or

SOURCE ThermoGenesis Corp.
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,769.55 +297.18 1.80%
S&P 500 1,985.85 +34.49 1.77%
NASDAQ 4,776.2540 +68.4790 1.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs